Hui‐Chiu Chang

2.8k total citations
52 papers, 2.4k citations indexed

About

Hui‐Chiu Chang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hui‐Chiu Chang has authored 52 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 18 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Hui‐Chiu Chang's work include Inflammatory mediators and NSAID effects (10 papers), Protease and Inhibitor Mechanisms (9 papers) and Peptidase Inhibition and Analysis (8 papers). Hui‐Chiu Chang is often cited by papers focused on Inflammatory mediators and NSAID effects (10 papers), Protease and Inhibitor Mechanisms (9 papers) and Peptidase Inhibition and Analysis (8 papers). Hui‐Chiu Chang collaborates with scholars based in Taiwan. Hui‐Chiu Chang's co-authors include Wen‐Chun Hung, Li‐Teh Liu, Lea‐Yea Chuang, Jentaie Shiea, Mei‐Ren Pan, Wei‐Lung Tseng, Ming‐Chuan Hsu, Lien‐Chai Chiang, Chun‐Yu Cho and Ming‐Feng Hou and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and Cancer Research.

In The Last Decade

Hui‐Chiu Chang

52 papers receiving 2.3k citations

Peers

Hui‐Chiu Chang
Peter J. Wirth United States
Hiromasa Tojo Japan
Lijun Yang China
Hans Adomat Canada
Yue Chen China
Curtis L. Ashendel United States
Mariafrancesca Scalise Italy
Egidio Iorio Italy
Yasuaki Kabe Japan
Massimo Donadelli Italy
Peter J. Wirth United States
Hui‐Chiu Chang
Citations per year, relative to Hui‐Chiu Chang Hui‐Chiu Chang (= 1×) peers Peter J. Wirth

Countries citing papers authored by Hui‐Chiu Chang

Since Specialization
Citations

This map shows the geographic impact of Hui‐Chiu Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Chiu Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Chiu Chang more than expected).

Fields of papers citing papers by Hui‐Chiu Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Chiu Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Chiu Chang. The network helps show where Hui‐Chiu Chang may publish in the future.

Co-authorship network of co-authors of Hui‐Chiu Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Chiu Chang. A scholar is included among the top collaborators of Hui‐Chiu Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Chiu Chang. Hui‐Chiu Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hung, Wen‐Chun, Wei‐Lung Tseng, Jentaie Shiea, & Hui‐Chiu Chang. (2009). Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. Cancer Letters. 288(2). 156–161. 98 indexed citations
2.
Hsu, Ming‐Chuan, Chee‐Yin Chai, Ming‐Feng Hou, et al.. (2008). Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu. Modern Pathology. 21(5). 609–616. 26 indexed citations
3.
Pan, Mei‐Ren, Ming‐Feng Hou, Hui‐Chiu Chang, & Wen‐Chun Hung. (2008). Cyclooxygenase-2 Up-regulates CCR7 via EP2/EP4 Receptor Signaling Pathways to Enhance Lymphatic Invasion of Breast Cancer Cells*. Journal of Biological Chemistry. 283(17). 11155–11163. 94 indexed citations
4.
5.
Pan, Mei‐Ren, Hui‐Chiu Chang, & Wen‐Chun Hung. (2008). Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases. Cellular Signalling. 20(6). 1134–1141. 61 indexed citations
6.
7.
Hung, Wen‐Chun, et al.. (2008). The Kazal motifs of RECK protein inhibit MMP‐9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo. Journal of Cellular and Molecular Medicine. 12(6b). 2781–2789. 42 indexed citations
8.
Hsu, Ming‐Chuan, Hui‐Chiu Chang, & Wen‐Chun Hung. (2007). HER-2/neu transcriptionally activates Jab1 expression via the AKT/β-catenin pathway in breast cancer cells. Endocrine Related Cancer. 14(3). 655–667. 27 indexed citations
9.
10.
11.
Cho, Chun‐Yu, et al.. (2007). Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells. Journal of Cellular Physiology. 213(1). 65–69. 45 indexed citations
12.
Wang, Chie‐Hong, Hui‐Chiu Chang, & Wen‐Chun Hung. (2006). p16 inhibits matrix metalloproteinase‐2 expression via suppression of Sp1‐mediated gene transcription. Journal of Cellular Physiology. 208(1). 246–252. 26 indexed citations
13.
Chang, Hui‐Chiu, Fang‐Rong Chang, Yang‐Chang Wu, & Yung‐Hsiung Lai. (2004). Anti‐Cancer Effect of Liriodenine on Human Lung Cancer Cells. The Kaohsiung Journal of Medical Sciences. 20(8). 365–371. 37 indexed citations
14.
Chang, Hui‐Chiu, et al.. (2003). Involvement of PKA and Sp1 in the induction of p27Kip1 by tamoxifen. Biochemical Pharmacology. 66(3). 371–377. 20 indexed citations
15.
Liu, Li‐Teh, et al.. (2003). RECK is a target of Epstein–Barr virus latent membrane protein 1. Oncogene. 22(51). 8263–8270. 55 indexed citations
16.
Liu, Li‐Teh, et al.. (2003). Enhancement of chemotherapeutic drug-induced apoptosis by a cyclooxygenase-2 inhibitor in hypopharyngeal carcinoma cells. Cancer Letters. 201(2). 157–163. 12 indexed citations
17.
Chang, Hui‐Chiu, Li‐Teh Liu, & Wen‐Chun Hung. (2003). Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK. Cellular Signalling. 16(6). 675–679. 59 indexed citations
18.
Hung, Wen‐Chun, et al.. (2000). Induction of p27KIP1 as a Mechanism Underlying NS398-Induced Growth Inhibition in Human Lung Cancer Cells. Molecular Pharmacology. 58(6). 1398–1403. 65 indexed citations
19.
Chang, Hui‐Chiu, et al.. (1999). Inhibitory effect of mimosine on proliferation of human lung cancer cells is mediated by multiple mechanisms. Cancer Letters. 145(1-2). 1–8. 46 indexed citations
20.
Hung, Wen‐Chun, Hui‐Chiu Chang, & Lea‐Yea Chuang. (1998). Transforming Growth Factor β 1 Potently Activates CPP32-like Proteases in Human Hepatoma Cells. Cellular Signalling. 10(7). 511–515. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter J. Wirth Breakdown of academic impact, for papers by Hiromasa Tojo Breakdown of academic impact, for papers by Lijun Yang Breakdown of academic impact, for papers by Hans Adomat Breakdown of academic impact, for papers by Yue Chen Breakdown of academic impact, for papers by Curtis L. Ashendel Breakdown of academic impact, for papers by Mariafrancesca Scalise Breakdown of academic impact, for papers by Egidio Iorio Breakdown of academic impact, for papers by Yasuaki Kabe Breakdown of academic impact, for papers by Massimo Donadelli
Rankless by CCL
2026